Sindh Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.90 M
as on 24-10-2024
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 M
as on 24-10-2024
- Satisfied Charges ₹ 2.95 M
as on 24-10-2024
- Revenue 7.17%
(FY 2023)
- Profit 34.18%
(FY 2023)
- Ebitda 31.40%
(FY 2023)
- Net Worth 272.37%
(FY 2023)
- Total Assets -5.29%
(FY 2023)
About Sindh Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.90 M.
The company currently has active open charges totaling ₹1.30 M. The company has closed loans amounting to ₹2.95 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Bhatija, Deepak Bhatija, Sunita Bhatija, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85111UP1988PTC009515
- Company No.
009515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sindh Pharma?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Bhatija  | Director | 07-Apr-1988 | Current |
| Deepak Bhatija | Director | 07-Apr-1988 | Current |
| Sunita Bhatija | Director | 16-May-2007 | Current |
| Kiran Bhatija | Director | 07-Apr-1988 | Current |
| Ankit Bhatija | Director | 28-Oct-2009 | Current |
| Aman Bhatija | Director | 28-Oct-2009 | Current |
Financial Performance of Sindh Pharma.
Sindh Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.17% increase. The company also saw a substantial improvement in profitability, with a 34.18% increase in profit. The company's net worth Soared by an impressive increase of 272.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sindh Pharma?
In 2023, Sindh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panchsheel Pharmaceuticals Private LimitedActive 44 yearsSanjay Bhatija, Deepak Bhatija and 5 more are mutual person
- Biota Medicia Private LimitedActive 13 years 6 months
Sanjay Bhatija, Sunita Bhatija and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jul 2021 | ₹1.30 M | Open |
Kotak Mahindra Prime Limited Creation Date: 31 Mar 2014 | ₹1.00 M | Satisfied |
Uco Bank Creation Date: 23 Dec 2011 | ₹0.65 M | Satisfied |
How Many Employees Work at Sindh Pharma?
Unlock and access historical data on people associated with Sindh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sindh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sindh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
